Related Experiment Video

Updated: Jun 25, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines

Andrew J Pollard1, Kirsten P Perrett, Peter C Beverley

  • 1Department of Paediatrics, University of Oxford, Level 2, Children's Hospital, Oxford, UK. andrew.pollard@paediatrics.ox.ac.uk

Nature Reviews. Immunology
|February 14, 2009
PubMed

Insights

Protein-polysaccharide conjugate vaccines significantly reduce childhood meningitis and pneumonia. However, vaccine-induced immunity wanes quickly, necessitating strategies for sustained population protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Polysaccharide-encapsulated bacteria are primary causes of pediatric bacterial meningitis and pneumonia.
  • Protein-polysaccharide conjugate vaccines have successfully reduced disease burden and mortality in developed nations.
  • These vaccines provide protection through direct immunization and herd immunity.

Purpose of the Study:

  • To review the impact of protein-polysaccharide conjugate vaccines on childhood infectious diseases.
  • To highlight the waning of vaccine-induced immunity after early childhood vaccination.
  • To advocate for strategies ensuring sustained population-level protection.

Main Methods:

  • This article is a Science and Society review, synthesizing existing knowledge.
  • It examines the immunological response to conjugate vaccines.
  • It discusses epidemiological data on disease reduction and waning immunity.

Main Results:

  • Conjugate vaccines have dramatically decreased the incidence of diseases caused by polysaccharide-encapsulated organisms.
  • Immunity wanes rapidly in early childhood following vaccination.
  • Herd immunity contributes significantly to disease reduction.

Conclusions:

  • Continued widespread use of conjugate vaccines in developing countries is expected to prevent millions of deaths.
  • The rapid waning of vaccine-induced immunity necessitates the development of strategies for long-term protection.
  • Sustained public health efforts are crucial to maintain the gains achieved by vaccination programs.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...